The risk score for each patient was calculated as follows: Risk score = 0.1475 × expression level of GSDME + 0.2859 × expression level of PLK1. Based on the median risk score, HCC patients were divided into high- and low-risk groups (Figure 3A). Here, PLK1 is linked to hepatocellular carcinoma.